Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Grilli

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
American Heart Journal|July 11, 2025
Accurate Fick cardiac output estimation: direct and simultaneous oxygen consumption measurement is imperative in heart failureMarlus Karsten, Carlo Vignati, Beatrice Pezzuto, et al.
International Journal of Cardiology. Heart & Vasculature|May 19, 2025
The role of impaired iron transport on exercise performance and prognosis in patients with chronic heart failureJeness Campodonico, Alice Bonomi, Marina Alimento, et al.
European Radiology|January 24, 2023
Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonanceGiovanni Donato Aquaro, Carmelo De Gori, Giulia Grilli, et al.
Plos One|July 16, 2025
Nasal vs. oral BREATHing WIn Strategies in healthy individuals during cardiorespiratory Exercise testing (BreathWISE)Massimo Mapelli, Elisabetta Salvioni, Irene Mattavelli, et al.
Circulation. Cardiovascular Imaging|April 2, 2024
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation CarriersFrancesco Negri, Giuseppe Damiano Sanna, Giulia Di Giovanna, et al.
International Journal of Molecular Sciences|August 28, 2025
Short-term effects of DAPAgliflozin on Lung fUNction, sleep apneas, and circulatinG surfactant protein B in Heart Failure with reduced ejection fraction (DAPA-LUNG-HF)Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, et al.
Frontiers in Cardiovascular Medicine|April 1, 2025
Dapagliflozin effects on exercise, cardiac remodeling, biomarkers, and renal and pulmonary function in heart failure patients: not as good as expected?Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, et al.
International Journal of Cardiology|January 19, 2024
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypesBeatrice Musumeci, Giacomo Tini, Elena Biagini, et al.
JACC. Advances|June 28, 2024
Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based AnalysisAlessandro Pierri, Stefano Albani, Marco Merlo, et al.
Frontiers in Cardiovascular Medicine|July 18, 2024
A matter of sex-persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter studyGiulia Grilli, Elisabetta Salvioni, Federica Moscucci, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
American Heart Journal|July 11, 2025
Accurate Fick cardiac output estimation: direct and simultaneous oxygen consumption measurement is imperative in heart failureMarlus Karsten, Carlo Vignati, Beatrice Pezzuto, et al.
International Journal of Cardiology. Heart & Vasculature|May 19, 2025
The role of impaired iron transport on exercise performance and prognosis in patients with chronic heart failureJeness Campodonico, Alice Bonomi, Marina Alimento, et al.
European Radiology|January 24, 2023
Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonanceGiovanni Donato Aquaro, Carmelo De Gori, Giulia Grilli, et al.
Plos One|July 16, 2025
Nasal vs. oral BREATHing WIn Strategies in healthy individuals during cardiorespiratory Exercise testing (BreathWISE)Massimo Mapelli, Elisabetta Salvioni, Irene Mattavelli, et al.
Circulation. Cardiovascular Imaging|April 2, 2024
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation CarriersFrancesco Negri, Giuseppe Damiano Sanna, Giulia Di Giovanna, et al.
International Journal of Molecular Sciences|August 28, 2025
Short-term effects of DAPAgliflozin on Lung fUNction, sleep apneas, and circulatinG surfactant protein B in Heart Failure with reduced ejection fraction (DAPA-LUNG-HF)Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, et al.
Frontiers in Cardiovascular Medicine|April 1, 2025
Dapagliflozin effects on exercise, cardiac remodeling, biomarkers, and renal and pulmonary function in heart failure patients: not as good as expected?Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, et al.
International Journal of Cardiology|January 19, 2024
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypesBeatrice Musumeci, Giacomo Tini, Elena Biagini, et al.
JACC. Advances|June 28, 2024
Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based AnalysisAlessandro Pierri, Stefano Albani, Marco Merlo, et al.
Frontiers in Cardiovascular Medicine|July 18, 2024
A matter of sex-persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter studyGiulia Grilli, Elisabetta Salvioni, Federica Moscucci, et al.
Pageof 3